Quantinno Capital Management’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Quantinno Capital Management's NVAX Position: Q3 2026 in Review
Quantinno Capital Management reduced its Novavax (NVAX) stake by 73% in Q3 2026, selling an estimated $1.55M and leaving 63,851 shares worth $690K. The position accounts for ﹤0.01% of the portfolio, ranked #3008.
Quantinno Capital Management first reported a position in NVAX in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.23M in Q2 2026. 259 funds tracked by Wall St. Rank hold NVAX as of Q3 2026.
- Quantinno Capital Management held 63,851 shares of Novavax worth $690K as of Q3 2026.
- Quantinno Capital Management sold 173,058 Novavax shares in Q3 2026, an estimated $1.55M.
- Novavax made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #3008 holding.
- Quantinno Capital Management first reported a position in Novavax in Q2 2025 and has held it in 6 quarters since.
- Quantinno Capital Management's Novavax position peaked at $2.23M in Q2 2026.
- 259 funds tracked by Wall St. Rank held Novavax as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.